Loading company…
Riskpilot
← Back to search
Sign in
Get full access
INNHERRED ULTRALYDKLINIKK AS
AS
Active
Org 927828618
Moafjæra 10, 7606 Levanger
Other human health activities n.e.c. · NACE 8699
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 901K
+9% vs 2023
EBITDA margin
4.0%
-35% vs 2023
Equity ratio
62.9%
Financial strength
Net profit 2024
NOK 19K
-42% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 901K
+9%
EBITDA
NOK 36K
-35%
Net profit
NOK 19K
-42%
Total assets
NOK 245K
+47%
Equity
NOK 154K
+14%
Employees
0
—
Company information
Legal name
INNHERRED ULTRALYDKLINIKK AS
Org number
927828618
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
28. september 2021
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Ultralydundersøkelser av gravide, samt aktiviteter som naturlig faller sammen med dette.
Contact
Address
Moafjæra 10, 7606 Levanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities n.e.c.
Companies in Levanger
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
723
825
901
Staff expenses
−34
−174
−219
EBITDA
89
55
36
Depreciation & amort.
−13
−13
−13
EBIT
76
43
24
Net financials
−1
−2
0
Profit before tax
75
41
24
Tax
17
9
5
Net profit
58
32
19
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
274
167
245
Equity
104
136
154
Long-term debt
0
0
0
Short-term debt
171
31
91
Total debt
171
31
91
Financial ratios
5-year trend
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
2022
2024
Equity ratio
62.9%
This company
38.2%
Market median
+65% vs market
2022
2024
Return on equity
12.1%
This company
18.4%
Market median
+34% vs market
2022
2024
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
2022
2024
Asset turnover
3.67×
This company
1.12×
Market median
+228% vs market
2022
2024
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
ES
Elin Sundvik
Board of Directors
2021
LH
Liv Hanne Gansmo
Chairman
2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of INNHERRED ULTRALYDKLINIKK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Elin Sundvik
Board of Directors
0 companies
Liv Hanne Gansmo
Chairman
0 companies